BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 31293655)

  • 21. Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation.
    Lou W; Chen J; Ding B; Chen D; Zheng H; Jiang D; Xu L; Bao C; Cao G; Fan W
    J Transl Med; 2018 Sep; 16(1):266. PubMed ID: 30268144
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ARK5 promotes invasion and migration in hepatocellular carcinoma cells by regulating epithelial-mesenchymal transition.
    Ye Z; Chen X; Chen X
    Oncol Lett; 2018 Feb; 15(2):1511-1516. PubMed ID: 29434843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
    Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
    Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of FOXM1 is associated with EMT and is a predictor of poor prognosis in non-small cell lung cancer.
    Kong FF; Qu ZQ; Yuan HH; Wang JY; Zhao M; Guo YH; Shi J; Gong XD; Zhu YL; Liu F; Zhang WY; Jiang B
    Oncol Rep; 2014 Jun; 31(6):2660-8. PubMed ID: 24715097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. KIAA0101 (OEACT-1), an expressionally down-regulated and growth-inhibitory gene in human hepatocellular carcinoma.
    Guo M; Li J; Wan D; Gu J
    BMC Cancer; 2006 Apr; 6():109. PubMed ID: 16646990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. KIAA0101 mRNA expression in the peripheral blood of hepatocellular carcinoma patients: Association with some clinicopathological features.
    Abdelgawad IA; Radwan NH; Hassanein HR
    Clin Biochem; 2016 Jul; 49(10-11):787-91. PubMed ID: 26968109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
    Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG
    J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The circular RNA ciRS-7 (Cdr1as) acts as a risk factor of hepatic microvascular invasion in hepatocellular carcinoma.
    Xu L; Zhang M; Zheng X; Yi P; Lan C; Xu M
    J Cancer Res Clin Oncol; 2017 Jan; 143(1):17-27. PubMed ID: 27614453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. JARID2 promotes invasion and metastasis of hepatocellular carcinoma by facilitating epithelial-mesenchymal transition through PTEN/AKT signaling.
    Lei X; Xu JF; Chang RM; Fang F; Zuo CH; Yang LY
    Oncotarget; 2016 Jun; 7(26):40266-40284. PubMed ID: 27259236
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-379-5p inhibits tumor invasion and metastasis by targeting FAK/AKT signaling in hepatocellular carcinoma.
    Chen JS; Li HS; Huang JQ; Dong SH; Huang ZJ; Yi W; Zhan GF; Feng JT; Sun JC; Huang XH
    Cancer Lett; 2016 May; 375(1):73-83. PubMed ID: 26944318
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of MnSOD and FoxM1 Is Involved in Invasion and EMT Suppression by Isovitexin in Hepatocellular Carcinoma Cells.
    Qiu Y; Cao X; Liu L; Cao X; Yuan Q; Li X; Cui Y; Xu C; Zou C; Ren K; Cao J
    Cancer Manag Res; 2020; 12():5759-5771. PubMed ID: 32765079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition.
    Xu J; Zhang X; Wang H; Ge S; Gao T; Song L; Wang X; Li H; Qin Y; Zhang Z
    Biomed Pharmacother; 2017 Apr; 88():421-429. PubMed ID: 28122307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-650 Promotes the Metastasis and Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma by Directly Inhibiting LATS2 Expression.
    Han LL; Yin XR; Zhang SQ
    Cell Physiol Biochem; 2018; 51(3):1179-1192. PubMed ID: 30481780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MAP4K4 promotes epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma.
    Feng XJ; Pan Q; Wang SM; Pan YC; Wang Q; Zhang HH; Zhu MH; Zhang SH
    Tumour Biol; 2016 Aug; 37(8):11457-67. PubMed ID: 27010469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of forkhead box C1 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma.
    Xia L; Huang W; Tian D; Zhu H; Qi X; Chen Z; Zhang Y; Hu H; Fan D; Nie Y; Wu K
    Hepatology; 2013 Feb; 57(2):610-24. PubMed ID: 22911555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. AP-2β inhibits hepatocellular carcinoma invasion and metastasis through Slug and Snail to suppress epithelial-mesenchymal transition.
    Yang L; Qiu J; Xiao Y; Hu X; Liu Q; Chen L; Huang W; Li X; Li L; Zhang J; Ding X; Xiang S
    Theranostics; 2018; 8(13):3707-3721. PubMed ID: 30026878
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PTIP promotes recurrence and metastasis of hepatocellular carcinoma by regulating epithelial-mesenchymal transition.
    Leng S; Yang M; Zhao Y; Zhao J; Zeng Z; Yang Y; Yuan J; Lv B; Jun F; Wang B
    Oncotarget; 2017 Aug; 8(35):58184-58198. PubMed ID: 28938547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. microRNA-96-5p induces the epithelial-mesenchymal transition to promote the metastasis of hepatocellular carcinoma by post-transcriptionally downregulating Talin 1.
    Tang H; Liu Y; Cheng W; He Z; Zhou N
    Int J Clin Exp Pathol; 2019; 12(5):1897-1908. PubMed ID: 31934013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monoacylglycerol lipase promotes progression of hepatocellular carcinoma via NF-κB-mediated epithelial-mesenchymal transition.
    Zhu W; Zhao Y; Zhou J; Wang X; Pan Q; Zhang N; Wang L; Wang M; Zhan D; Liu Z; He X; Ma D; Liu S; Wang L
    J Hematol Oncol; 2016 Nov; 9(1):127. PubMed ID: 27884159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigation of Functional Synergism of CENPF and FOXM1 Identifies POLD1 as Downstream Target in Hepatocellular Carcinoma.
    Ho DW; Lam WM; Chan LK; Ng IO
    Front Med (Lausanne); 2022; 9():860395. PubMed ID: 35865168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.